Norges Bank’s Achillion Pharmaceuticals ACHN Stock Holding History

Norges Bank’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-34,447	Closed	-$124K	–	2112
2019 Q3	$124K	Hold	34,447	–	–	﹤0.01%	2084
2019 Q2	$92K	Hold	34,447	–	–	﹤0.01%	2089
2019 Q1	$102K	Hold	34,447	–	–	﹤0.01%	2107
2018 Q4	$55K	Hold	34,447	–	–	﹤0.01%	2109
2018 Q3	$127K	Sell	34,447 -1,814	-5%	-$5.41K	﹤0.01%	2124
2018 Q2	$102K	Hold	36,261	–	–	﹤0.01%	2115
2018 Q1	$135K	Sell	36,261 -820,815	-96%	-$2.69M	﹤0.01%	2120
2017 Q4	$2.47M	Hold	857,076	–	–	﹤0.01%	1955
2017 Q3	$3.85M	Buy	857,076 +386,784	+82%	+$1.72M	﹤0.01%	1904
2017 Q2	$2.16M	Sell	470,292 -381,344	-45%	-$1.53M	﹤0.01%	1977
2017 Q1	$3.58M	Sell	851,636 -267,860	-24%	-$1.11M	﹤0.01%	1937
2016 Q4	$4.62M	Hold	1,119,496	–	–	﹤0.01%	1881
2016 Q3	$8.66M	Buy	1,119,496 +355,677	+47%	+$3.02M	﹤0.01%	1716
2016 Q2	$5.96M	Buy	763,819 +729,372	+2,117%	+$6.26M	﹤0.01%	1823
2016 Q1	$266K	Hold	34,447	–	–	﹤0.01%	2160
2015 Q4	$372K	Hold	34,447	–	–	﹤0.01%	2191
2015 Q3	$238K	Hold	34,447	–	–	﹤0.01%	2233
2015 Q2	$305K	Hold	34,447	–	–	﹤0.01%	2215
2015 Q1	$340K	Sell	34,447 -135,284	-80%	-$1.69M	﹤0.01%	2232
2014 Q4	$2.08M	Hold	169,731	–	–	﹤0.01%	2089
2014 Q3	$1.69M	Buy	+169,731	New	+$1.58M	﹤0.01%	2133

Other funds holding ACHN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank's ACHN Position: Q4 2019 in Review

Norges Bank sold out of Achillion Pharmaceuticals (ACHN) in Q4 2019, closing a stake of 34,447 shares — an estimated $124K sold.

Norges Bank first reported a position in ACHN in Q3 2014 and held it in 21 quarters. The position peaked at $8.66M in Q3 2016. 132 funds tracked by Wall St. Rank hold ACHN as of Q4 2019.

Norges Bank reported no remaining Achillion Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
Norges Bank sold 34,447 Achillion Pharmaceuticals shares in Q4 2019, an estimated $124K.
Norges Bank first reported a position in Achillion Pharmaceuticals in Q3 2014 and held it in 21 quarters.
Norges Bank's Achillion Pharmaceuticals position peaked at $8.66M in Q3 2016.
132 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2019.

Based on Norges Bank's 13F filing for Q4 2019, filed 12 Feb 2020.